Modafinil, sleep deprivation, and cognitive function in military and medical settings

Military Medicine

Volumn 170, Issue 4, 2005, Pages 333-335

  Westcott, Kelli J ^a  

^a LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; AMPHETAMINE; CAFFEINE; CONTRACEPTIVE AGENT; CYCLOSPORIN; DIAZEPAM; DOPAMINE; MODAFINIL; NORADRENALIN; PHENYTOIN; PLACEBO; PROPRANOLOL; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; STEROID; THEOPHYLLINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ALERTNESS; ANXIETY DISORDER; ARMY; CARDIOVASCULAR SYMPTOM; CIRCADIAN RHYTHM; CIRCADIAN RHYTHM SLEEP DISORDER; CLINICAL TRIAL; COGNITION; DIURESIS; DRUG BLOOD LEVEL; DRUG DEPENDENCE; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; HEADACHE; HUMAN; IRRITABILITY; MILITARY MEDICINE; NARCOLEPSY; NAUSEA; NERVOUSNESS; REVIEW; RHINORRHEA; SHIFT WORKER; SIDE EFFECT; SLEEP APNEA SYNDROME; SLEEP DEPRIVATION; SLEEP DISORDER; SOLDIER; SORE THROAT; TREMOR; WAKEFULNESS;

EID: 17444425314     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.7205/MILMED.170.4.333     Document Type: Review

References (37)

1. Dula JD, Dula NL, Hamrick C, et al: The effect of working serial night shifts on the cognitive functioning of emergency physicians. Ann Emerg Med 2001; 38: 152-5.
2. Kuhn G: Circadian rhythm, shift work, and emergency medicine. Ann Emerg Med 2001; 37: 88-98.
3. Smith-Coggins R, Rosekind MR, Hurd S, Buccino KR: Relationship of day versus night sleep to physician performance and mood. Ann Emerg Med 1994; 24: 928-34.
4. Akerstedt T, Gillberg M: The circadian variation of experimentally displaced sleep. Sleep 1981; 4: 159-69.
5. Kryger MH, Roth T, Dment WC (editors): Behavioral effects of sleep loss. In: Principles and Practice of Sleep Medicine, Ed 3. pp 54-8. Philadelphia, PA, WB Saunders, 2000.
6. Weinger MB, Ancoli-Israel S: Sleep deprivation and clinical performance. JAMA 2002; 287: 955-7.
7. Scott AJ: Shift work and health. Prim Care 2000; 27: 1057-79
8. Buguet A, Moroz D: Modafinil-medical considerations for use in sustained operations. Aviat Space Environ Med 2003; 74: 659-63.
9. Storer JS, Floyd HH, Gill WL, et al: Effects of sleep deprivation on cognitive ability and skills of pediatrics residents. Acad Med 1989; 64: 29-32.
10. Robbins J, Gottlieb F: Sleep deprivation and cognitive testing in internal medicine house staff. West J Med 1990; 152: 82-6.
11. Samkoff JS, Jacques CHM: A review of studies concerning effects of sleep deprivation and fatigue on residents' performance. Acad Med 1991; 66: 687-93.
12. Owens JA: Sleep loss and fatigue in medical training. Curr Opin Pulm Med 2001; 7: 411-8.
13. Lin JS, Hou Y, Jouvet M: Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry, in the cat. Proc Natl Acad Sci USA 1996; 93: 14128-33.
14. Engber TM: Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil. Neurosci Lett 1998; 24: 95-8.
15. Engber TM, Dennis SA, Jones BE, et al: Brain regional substrates for the actions of the novel wake-promoting agent modafinil in the rat: comparison with amphetamine. Neuroscience 1998; 87: 905-12.
16. Modafinil. In: Mosby's Drug Consult. Philadelphia, PA, Mosby, 2004.
17. Caldwell JA, Caldwell JL, Smythe NK, et al: A double-blind, placebo-controlled investigation of the efficacy of modafinil for sustaining the alertness and performance of aviators: a helicopter simulator study. Psychopharmacology (Berl) 2000; 150: 272-82.
18. Pigeau R, Naitoh P, Buguet A, et al: Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work: part 1: effects on mood, fatigue, cognitive performance and body temperature. J Sleep Res 1995; 4: 212-28.
19. Buguet A, Montmayeur A, Pigeau R, et al: Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work: part II: effects on two nights of recovery sleep. J Sleep Res 1995; 4: 229-41.
20. Wesensten J, Belenky G, Kautz MA, et al: Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine. Psychopharmacology (Berl) 2002; 159: 238-47.
21. Lyons T, French J: Modafinil: the unique properties of a new stimulant. Aviat Space Environ Med 1991; 62: 432-5.
22. Batejat DM, Lagarde DP: Naps and modafinil as countermeasures for the effects of sleep deprivation on cognitive performance. Aviat Space Environ Med 1999; 70: 493-8.
23. Touret M, Sallanon MM, Jouvet M, et al: Awakening properties of modafinil without paradoxical sleep rebound: comparative study with amphetamine in the rat. Neurosci Lett 1995; 189: 43.
24. Hou YP, Lin JS: Effects of modafinil and amphetamine on sleep-wake cycle after sleep deprivation in cats. Acta Pharmacol Sin 2001; 20: 813-8.
25. Lin JS, Gervasoni D, Vanni-Mercier G, etal: Effects of amphetamine and modafinil on the sleep/wake cycle during experimental hypersomnia induced by sleep deprivation in the cat. J Sleep Res 2000; 9: 89-96.
26. Besset A, Chetrit M, Carlander B, et al: Use of modafinil in the treatment of narcolepsy: a long term follow-up study. Neurophysiol Clin 1996; 26: 60-6.
27. Wong YN, King SP, Simcoe D: Open-label, single-dose pharmacokinetic study of modafinil tablets: influence of age and gender in normal subjects. J Clin Pharmacol 1999; 39: 281-8.
28. Wong YN, Simcoe D, Hartman LN, et al: A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers. J Clin Pharmacol 1999; 39: 30-40.
29. Chamba G, Khalfallah Y, Boissy I, et al: Effect of modafinil on plasma melatonin. cortisol and growth hormone rhythms, rectal temperature and performance in healthy subjects during a 36 h sleep deprivation. J Sleep Res 1998; 7: 105-14.
30. Jasinski DR: An evaluation of the abuse potential of modafinil using methyl-phenidate as a reference. J Psychopharmacol 2000; 14: 53-60.
31. Simon PA, Panissaud CA, Costentin J, et al: The stimulant effect of modafinil on wakefulness is not associated with an increase in anxiety in mice: a comparison with dexamphetamine. Psychopharmacology (Berl) 1994; 114: 597-600.
32. Warot D, Corruble E, Payan C, et al: Subjective effects of modafinil, a new central adrenergic stimulant in healthy volunteers: a comparison with amphetamine, caffeine and placebo. Eur Psychiatry 1993; 8: 201-8.
33. Comer AM, Spencer CM: Management of narcolepsy: defining the role of modafinil. Dis Manag Health Outcomes 2000; 8: 99-111.
34. Jasinski DR, Kovacevic-Ristanovic R: Evaluation of the abuse liability of modafinil and other drugs for excessive daytime sleepiness associated with narcolepsy. Clin Neuropharmacol 2000; 23: 149-56.
35. Cephalon Press Release: Cephalon announces positive results of Provigil: clinical study in shift work sleep disorders. West Chester, PA, Cephalon, Inc., October 23, 2002.
36. Provigil: drug may help sleepy residents, but use with caution, Residency Program Director's Alert. 2003; (Nov): 103-105.
37. Provigil: controversy and clarifications, Residency Program Director's Alert. 2003; (Dec): 113.